Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

Estrogen Receptor

  • Karin Dahlman-Wright
  • Chunyan ZhaoEmail author
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_241


Historical Background

In 1896, physician George Beatson observed that removal of the ovaries caused regression of mammary tumors in women. His experiments were the first to establish a link between ovarian secretions and breast cancer. Later in the early 1930s, the “female” sex hormones, estrone and estriol, could be isolated from human pregnancy urine, followed by isolation of a third estrogen, estradiol (E2), from pig follicular fluid. Shortly thereafter, a number of estrogenic compounds were synthesized and used therapeutically, but the mechanisms of estrogen action remained obscure. However, in 1958 Elwood Jensen produced a major breakthrough when he used a radioactive marker to demonstrate that only estrogen-responsive tissues were able to concentrate injected estrogen from the blood, suggesting the existence of estrogen-binding components, which were called “estrogen receptors (ERs).” Further...

This is a preview of subscription content, log in to check access.


  1. Carroll JS, Brown M. Estrogen receptor target gene: an evolving concept. Mol Endocrinol. 2006;20:1707–14.PubMedPubMedCentralCrossRefGoogle Scholar
  2. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, et al. Genome-wide analysis of estrogen receptor binding sites. Nat Genet. 2006;38:1289–97.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Cloonan N, Forrest AR, Kolle G, Gardiner BB, Faulkner GJ, Brown MK, et al. Stem cell transcriptome profiling via massive-scale mRNA sequencing. Nat Methods. 2008;5:613–9.PubMedPubMedCentralCrossRefGoogle Scholar
  4. Dahlman-Wright K, Cavailles V, Fuqua SA, Jordan VC, Katzenellenbogen JA, Korach KS, et al. International union of pharmacology. LXIV. Estrogen receptors. Pharmacol Rev. 2006;58:773–81.CrossRefPubMedGoogle Scholar
  5. Kang L, Zhang X, Xie Y, Tu Y, Wang D, Liu Z, et al. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol Endocrinol. 2010;24:709–21.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Kininis M, Kraus WL. A global view of transcriptional regulation by nuclear receptors: gene expression, factor localization, and DNA sequence analysis. Nucl Recept Signal. 2008;6:e005.PubMedPubMedCentralGoogle Scholar
  7. Kininis M, Chen BS, Diehl AG, Isaacs GD, Zhang T, Siepel AC, et al. Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters. Mol Cell Biol. 2007;27:5090–104.PubMedPubMedCentralCrossRefGoogle Scholar
  8. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A. 1996;93:5925–30.PubMedPubMedCentralCrossRefGoogle Scholar
  9. Martin LA, Farmer I, Johnston SR, Ali S, Dowsett M. Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation. Endocr Relat Cancer. 2005;12(Suppl 1):75–84.CrossRefGoogle Scholar
  10. Matthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv. 2003;3:281–92.CrossRefPubMedGoogle Scholar
  11. O’Lone R, Frith MC, Karlsson EK, Hansen U. Genomic targets of nuclear estrogen receptors. Mol Endocrinol. 2004;18:1859–75.CrossRefPubMedGoogle Scholar
  12. Ring A, Dowsett M. Mechanisms of tamoxifen resistance. Endocr Relat Cancer. 2004;11:643–58.CrossRefPubMedGoogle Scholar
  13. Spears M, Bartlett J. The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer. Expert Opin Ther Targets. 2009;13:665–74.CrossRefPubMedGoogle Scholar
  14. Welboren WJ, Stunnenberg HG, Sweep FC, Span PN. Identifying estrogen receptor target genes. Mol Oncol. 2007;1:138–43.PubMedPubMedCentralCrossRefGoogle Scholar
  15. Williams C, Edvardsson K, Lewandowski SA, Strom A, Gustafsson JA. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Oncogene. 2008;27:1019–32.CrossRefPubMedPubMedCentralGoogle Scholar
  16. Zhao C, Lam EW, Sunters A, Enmark E, De Bella MT, Coombes RC, et al. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation. Oncogene. 2003;22:7600–6.CrossRefPubMedGoogle Scholar
  17. Zhao C, Dahlman-Wright K, Gustafsson JA. Estrogen receptor beta: an overview and update. Nucl Recept Signal. 2008;6:e003.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of Biosciences and NutritionNovum, Karolinska InstitutetHuddingeSweden